Clinical Trial Update: HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding chemotherapy to HAART improves response in HIV infection and AIDS-related Kaposi's sarcoma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection
• Kaposi Sarcoma

Snippet

Sponsor: University of KwaZulu | Conditions: HIV, AIDS | Phase 4 | Status: COMPLETED